Document Detail

Treatment of acute pulmonary hypertension with inhaled nitric oxide.
MedLine Citation:
PMID:  7944746     Owner:  NLM     Status:  MEDLINE    
We examined the effectiveness of inhaled nitric oxide (NO) as a selective pulmonary vasodilator in acute pulmonary hypertension in an in vivo canine model with fixed cardiac output. In 5 dogs, total right heart bypass was instituted, and pulmonary hypertension was induced by infusion of the thromboxane analogue U-46619. During U-46619 infusion, NO was administered at 10 and 40 ppm for 5 minutes followed by breathing of the oxygen mixture without NO. Pump flow was held constant during the experiment. Infusion of the thromboxane analogue resulted in an increase in pulmonary vascular resistance and systemic vascular resistance from 147 +/- 83 to 740 +/- 126 and from 1,720 +/- 113 to 2,407 +/- 232, respectively. During inhalation of 10 ppm NO, pulmonary vascular resistance significantly decreased to 613 +/- 55 (p < 0.05) and further decreased to 527 +/- 163 with 40 ppm NO inhalation (p < 0.05). Systemic vascular resistance did not change during NO treatment (2,300 +/- 70 during 40 ppm NO). There was no increase in intrapulmonary shunting or methemoglobin levels during NO inhalation. In this setting, with a constant cardiac output throughout the experiment, NO acted as a selective pulmonary vasodilator without altering systemic vascular resistance. However, induced pulmonary vasoconstriction was only partially reversed by NO inhalation.
M Tönz; L K von Segesser; J Schilling; T F Lüscher; G Noll; B Leskosek; M I Turina
Related Documents :
7839766 - Acute pulmonary oedema in patients with primary pulmonary hypertension and normal pulmo...
16261276 - Simplified pulmonary vasodilatory testing in the cardiac catheterization laboratory wit...
1772126 - Initial treatment of pulmonary edema: a physiological approach.
11790646 - Continuous positive airway pressure treatment improves pulmonary hemodynamics in patien...
22071176 - A field study to estimate the vertical gas diffusivity and permeability of compacted ms...
17489866 - Comparison of propofol and isoflurane anesthesia in orthotopic pig-to-baboon cardiac xe...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  58     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1994 Oct 
Date Detail:
Created Date:  1994-11-10     Completed Date:  1994-11-10     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1031-5     Citation Subset:  AIM; IM    
Clinic for Cardiovascular Surgery, University Hospital, Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Administration, Inhalation
Hypertension, Pulmonary / drug therapy*,  physiopathology
Nitric Oxide / administration & dosage,  pharmacology*,  therapeutic use
Pulmonary Circulation / drug effects
Vascular Resistance / drug effects
Vasodilator Agents / administration & dosage,  pharmacology*,  therapeutic use
Reg. No./Substance:
0/Vasodilator Agents; 10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Regulation of pulmonary vascular resistance by endogenous and exogenous nitric oxide.
Next Document:  Determinants of low systemic vascular resistance during cardiopulmonary bypass.